Pub Date : 2024-06-26DOI: 10.1007/s12598-024-02759-w
Xue-Yu Man, Ze-Wen Sun, Shan-He Li, Gang Xu, Wen-Juan Li, Zhen-Lei Zhang, Hong Liang, Feng Yang
Cisplatin resistance is the main cause for the failure of cancer therapy. To solve the problem, we proposed to develop a novel human serum albumin (HSA) nanoplatform to integrate chemotherapy, photothermal therapy (PTT) and immunotherapy. To this end, we obtained a platinum compound (C5) with significant cytotoxicity in the cisplatin-resistant SKOV-3 cells (SKOV-3/DDP), and then innovatively constructed photosensitizer (indocyanine green (ICG))-encapsulated HSA-C5 complex nanoparticles (ICG@HSA-C5 NPs). The ICG@HSA-C5 NPs exhibited excellent photothermal performances in vitro and in vivo. Importantly, the in vivo results revealed that HSA enhanced the antitumor effect of C5 and that the combination of chemotherapy and PTT could significantly inhibit cisplatin-resistant tumor growth and improved the targeting abilities of C5 and ICG, and reduced their side effects. We also confirmed that ICG@HSA-C5 NPs killed the SKOV-3/DDP cells via gasdermin E (GSDME)-mediated pyroptosis and pyroptosis-induced immune responses, thereby synergistically leading to the death of the SKOV-3/DDP cells.
{"title":"Development of a Pt(II) compound based on indocyanine green@human serum albumin nanoparticles: integrating phototherapy, chemotherapy and immunotherapy to overcome tumor cisplatin resistance","authors":"Xue-Yu Man, Ze-Wen Sun, Shan-He Li, Gang Xu, Wen-Juan Li, Zhen-Lei Zhang, Hong Liang, Feng Yang","doi":"10.1007/s12598-024-02759-w","DOIUrl":"https://doi.org/10.1007/s12598-024-02759-w","url":null,"abstract":"<p>Cisplatin resistance is the main cause for the failure of cancer therapy. To solve the problem, we proposed to develop a novel human serum albumin (HSA) nanoplatform to integrate chemotherapy, photothermal therapy (PTT) and immunotherapy. To this end, we obtained a platinum compound (C5) with significant cytotoxicity in the cisplatin-resistant SKOV-3 cells (SKOV-3/DDP), and then innovatively constructed photosensitizer (indocyanine green (ICG))-encapsulated HSA-C5 complex nanoparticles (ICG@HSA-C5 NPs). The ICG@HSA-C5 NPs exhibited excellent photothermal performances in vitro and in vivo. Importantly, the in vivo results revealed that HSA enhanced the antitumor effect of C5 and that the combination of chemotherapy and PTT could significantly inhibit cisplatin-resistant tumor growth and improved the targeting abilities of C5 and ICG, and reduced their side effects. We also confirmed that ICG@HSA-C5 NPs killed the SKOV-3/DDP cells via gasdermin E (GSDME)-mediated pyroptosis and pyroptosis-induced immune responses, thereby synergistically leading to the death of the SKOV-3/DDP cells.</p><h3 data-test=\"abstract-sub-heading\">Graphical abstract</h3>","PeriodicalId":749,"journal":{"name":"Rare Metals","volume":null,"pages":null},"PeriodicalIF":8.8,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141508589","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
High-performance bifunctional oxygen electrocatalysts that simultaneously boost the sluggish oxygen reduction reaction (ORR) and oxygen evolution reaction (OER) need to be developed for advanced rechargeable Zn-air battery applications. In this work, a zeolitic imidazolate framework (ZIF)-phase conversion associated with a subsequent thermal fixing strategy was developed to fabricate bimetallic CoFe single atoms/clusters embedded in N-doped carbon (denoted as CoFe–N–C) nanorods, which can serve as efficient bifunctional ORR/OER electrocatalysts. Microstructural observation and X-ray absorption spectroscopy analysis confirm the co-existence of highly active Co/Fe–Nx dual sites and CoFe alloy nanoclusters. X-ray photoelectron spectroscopy (XPS) results prove that implanting secondary Fe atoms into Co–N–C matrix nanorods can induce electronic redistribution of atomic Co/Fe active sites and generate synergistic effects, which would optimize the adsorption energy of the reaction intermediates and thus enhance the bifunctional ORR/OER activity. The bimetallic CoFe–N–C nanorods exhibit significantly enhanced bifunctional ORR/OER activity and stability than the monometallic Co/Fe–N–C nanorods in alkaline electrolytes in terms of a very positive half-wave potential of 0.90 V (vs. reversible hydrogen electrode (RHE)) for ORR, and an overpotential of 440 mV to reach current density of 10 mA·cm−2 for OER, yielding a small overpotential gap of 0.77 V. Furthermore, the rechargeable Zn-air batteries using bimetallic CoFe–N–C nanorods as air–cathode catalyst demonstrates peak power density of 200.7 mW·cm−2 and robust cycling stability of up to 200 h, corresponding to 1200 discharge–charge cycles.